Description: Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Home Page: www.harvardbioscience.com
HBIO Technical Analysis
84 October Hill Road
Holliston,
MA
01746
United States
Phone:
508 893 8999
Officers
Name | Title |
---|---|
Mr. James W. Green | Pres, CEO & Chairman |
Mr. Michael A. Rossi | Chief Financial Officer |
Mr. Kenneth Fletcher Olson | Exec. Officer |
Mr. David Balcom | Sr. VP of Operations |
Mr. John J. Fry | Chief Legal Counsel & Corp. Sec. |
Mr. Ryan Wallace | Sr. VP of Global Sales - Preclinical Systems |
David Sirois | Director of Corp. Accounting & SEC Reporting |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 14.9254 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.5973 |
Price-to-Sales TTM: | 0.8475 |
IPO Date: | 2000-12-07 |
Fiscal Year End: | December |
Full Time Employees: | 475 |